SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (50712)1/31/2019 3:20:50 PM
From: atticus4paws  Read Replies (1) | Respond to of 52153
 
Yes Miljenko, I agree. I wonder if the placebo group in VKTX Ph2 were on an exercise regimen? Anyway, my prior point was that MDGL/VKTX results crush those of BMY's FGF21 by an order of magnitude (if I'm not mistaken) in terms of liver fat reduction.